NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Shanghai 6th People's Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS